Our results showed that induction of DM, which was associated with reduced expression levels of Egr-1, also resulted in increased systemic levels of CD11b+ cells, and after induction of arteriogenesis, in reduced levels of CD11b+, CD3+, and CD19+ cells. The gene discussed is CD19; the disease is diabetes mellitus.